Implications of protein flexibility for drug discovery

被引:0
|
作者
Simon J. Teague
机构
[1] AstraZeneca R&D Charnwood,
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
A large number of pharmaceutically relevant targets have been shown to be flexible, which are collected in this article. This comprehensive list of present and historical pharmaceutical targets provides the basis for questioning the relevance of the rigid receptor hypothesis, which is commonly used during in silico drug design.The role of protein flexibility in future pharmaceutical targets is likely to be even greater than in the past. Presently under-exploited target classes, such as ion channels, nuclear hormone receptors and transporters, have functions that are inextricably bound up with their structural flexibility.This article uses illustrative examples to discuss the implications of protein flexibility in drug discovery, and highlights how it could be exploited in drug design.
引用
收藏
页码:527 / 541
页数:14
相关论文
共 50 条
  • [11] Protein flexibility and species specificity in structure-based drug discovery: Dihydrofolate reductase as a test system
    Bowman, Anna L.
    Lerner, Michael G.
    Carlson, Heather A.
    [J]. Journal of the American Chemical Society, 2007, 129 (12): : 3634 - 3640
  • [12] Protein flexibility and species specificity in structure-based drug discovery: Dihydrofolate reductase as a test system
    Bowman, Anna L.
    Lerner, Michael G.
    Carlson, Heather A.
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2007, 129 (12) : 3634 - 3640
  • [13] Implications of salivary proteomics in drug discovery and development: a focus on cancer drug discovery
    Hu, Shen
    Yen, Yun
    Ann, David
    Wong, David T.
    [J]. DRUG DISCOVERY TODAY, 2007, 12 (21-22) : 911 - 916
  • [14] Protein Crystallography in Drug Discovery
    Canduri, Fernanda
    de Azevedo, Walter Filgueira, Jr.
    [J]. CURRENT DRUG TARGETS, 2008, 9 (12) : 1048 - 1053
  • [15] Spider venomics: implications for drug discovery
    Pineda, Sandy S.
    Undheim, Eivind A. B.
    Rupasinghe, Darshani B.
    Ikonomopoulou, Maria P.
    King, Glenn F.
    [J]. FUTURE MEDICINAL CHEMISTRY, 2014, 6 (15) : 1699 - 1714
  • [16] Estrogen and ApoE: Drug discovery implications
    Smith, JD
    Levin, JA
    [J]. DRUG DISCOVERY AND DEVELOPMENT FOR ALZHEIMER'S DISEASE, 2000, 2002, : 129 - 136
  • [17] The evasive nature of drug efficacy:: implications for drug discovery
    Galandrin, Segolene
    Oligny-Longpre, Genevieve
    Bouvier, Michel
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2007, 28 (08) : 423 - 430
  • [18] Robotic systems - Adding speed and flexibility to the drug discovery process
    Schneider, I
    [J]. GENETIC ENGINEERING NEWS, 1999, 19 (02): : 14 - +
  • [19] Computer-aided drug discovery: Dealing with flexibility and protonation
    McCammon, J.
    Miao, Yinglong
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [20] Structure and function of G protein-coupled receptor oligomers: implications for drug discovery
    Schonenbach, Nicole S.
    Hussain, Sunyia
    O'Malley, Michelle A.
    [J]. WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY, 2015, 7 (03) : 408 - 427